Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Nitroglycerin patch
DRUG
2 trials
Sponsors
Maastricht Radiation Oncology
, GF Strong Rehabilitation Centre
Conditions
Myofascial Trigger Points
Non Small Cell Lung Cancer (NSCLC)
Phase 2
Nitroglycerin in Non-small Cell Lung Cancer
Terminated
NCT01210378
Maastricht Radiation Oncology
Non Small Cell Lung Cancer (NSCLC)
Start: 2011-12-31
End: 2017-03-31
Updated: 2019-02-15
Unknown Phase
Topical Nitrates for Myofascial Trigger Points
Completed
NCT01675700
GF Strong Rehabilitation Centre
Myofascial Trigger Points
Start: 2009-01-31
End: 2009-12-31
Updated: 2012-08-30
Related Papers
Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial.
2019-12-13
12 citations
Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT.
2017-08-25
18 citations
Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.
2015-09-04
61 citations
Abstract B144: Hypoxia imaging with [18F]HX4 PET compared with [18F]FMISO and [18F]FAZA: From preclinical to clinical studies.
Molecular Cancer Therapeutics
2013-11-01
1 citations